Brief: Senzime Q3 EBITDA SEK -25.477 Thousand
26/10/2023 06:00
Oct 26 (Reuters) - Senzime Q3 EPS SEK -0.33. * Q3 sales SEK 9.154 million * Q3 adjusted gross margin 69.4%
Recent news on Senzime AB (publ)
See all newsBrief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona